The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study

Vladimir Grošić,1 Petra Folnegovic Grošić,2 Petra Kalember,3,4 Maja Bajs Janović,2 Marko Radoš,3,4 Mate Mihanović,1 Neven Henigsberg3,51Psychiatric Hospital Sveti Ivan, Zagreb, 2University Hospital Center Zagreb, University of Zagreb, Zagreb, 3Polyclinic Neuron, Cro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Grošić V, Folnegović Grošić P, Kalember P, Bajs Janović M, Radoš M, Mihanović M, Henigsberg N
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://doaj.org/article/1e9212947ea445d7855b9a8c311f956b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e9212947ea445d7855b9a8c311f956b
record_format dspace
spelling oai:doaj.org-article:1e9212947ea445d7855b9a8c311f956b2021-12-02T00:34:14ZThe effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study1178-2021https://doaj.org/article/1e9212947ea445d7855b9a8c311f956b2014-07-01T00:00:00Zhttp://www.dovepress.com/the-effect-of-atypical-antipsychotics-on-brain-n-acetylaspartate-level-a17504https://doaj.org/toc/1178-2021 Vladimir Grošić,1 Petra Folnegovic Grošić,2 Petra Kalember,3,4 Maja Bajs Janović,2 Marko Radoš,3,4 Mate Mihanović,1 Neven Henigsberg3,51Psychiatric Hospital Sveti Ivan, Zagreb, 2University Hospital Center Zagreb, University of Zagreb, Zagreb, 3Polyclinic Neuron, Croatian Institute for Brain Research, Zagreb, 4Department of Neuropharmacology and Behavioral Pharmacology, Croatian Institute for Brain Research, University of Zagreb, Zagreb, 5Vrapče University Hospital, University of Zagreb, Zagreb, CroatiaPurpose: To investigate the correlates of a clinical therapeutic response by using the parameters measured by proton magnetic resonance spectroscopy after the administration of atypical antipsychotics.Patients and methods: Twenty-five antipsychotic-naïve first-episode patients with schizophrenia were monitored for 12 months. The patients were evaluated using 1H magnetic resonance spectroscopy in the dorsolateral prefrontal cortex and Positive and Negative Syndrome Scale, Clinical Global Impression Scale of Severity, Tower of London – Drexel University, Letter–Number Span Test, Trail Making Test A, and Personal and Social Performance Scale. They were administered atypical antipsychotics, starting with quetiapine. In the absence of a therapeutic response, another antipsychotic was introduced.Results: After 12 study months, the N-acetylaspartate/creatine (NAA/Cr) level did not significantly change at the whole-group level. Additional analysis revealed a significant rise in the NAA/Cr level in the study group that stayed on the same antipsychotic throughout the study course (P=0.008) and a significant drop in NAA/Cr in the study group that switched antipsychotics (P=0.005). On the whole-group level, no significant correlations between NAA/Cr values and other scores were found at either baseline or after 12 study months.Conclusion: One-year treatment with atypical antipsychotics administered to antipsychotic-naïve patients didn’t result in a significant rise in the NAA/Cr ratio. However, a significant rise was witnessed in the study group in which a satisfactory therapeutic response had been achieved with a single antipsychotic administration.Keywords: schizophrenia, atypical antipsychotics, NAA, MRSGrošić VFolnegović Grošić PKalember PBajs Janović MRadoš MMihanović MHenigsberg NDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2014, Iss default, Pp 1243-1253 (2014)
institution DOAJ
collection DOAJ
language EN
topic Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Grošić V
Folnegović Grošić P
Kalember P
Bajs Janović M
Radoš M
Mihanović M
Henigsberg N
The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
description Vladimir Grošić,1 Petra Folnegovic Grošić,2 Petra Kalember,3,4 Maja Bajs Janović,2 Marko Radoš,3,4 Mate Mihanović,1 Neven Henigsberg3,51Psychiatric Hospital Sveti Ivan, Zagreb, 2University Hospital Center Zagreb, University of Zagreb, Zagreb, 3Polyclinic Neuron, Croatian Institute for Brain Research, Zagreb, 4Department of Neuropharmacology and Behavioral Pharmacology, Croatian Institute for Brain Research, University of Zagreb, Zagreb, 5Vrapče University Hospital, University of Zagreb, Zagreb, CroatiaPurpose: To investigate the correlates of a clinical therapeutic response by using the parameters measured by proton magnetic resonance spectroscopy after the administration of atypical antipsychotics.Patients and methods: Twenty-five antipsychotic-naïve first-episode patients with schizophrenia were monitored for 12 months. The patients were evaluated using 1H magnetic resonance spectroscopy in the dorsolateral prefrontal cortex and Positive and Negative Syndrome Scale, Clinical Global Impression Scale of Severity, Tower of London – Drexel University, Letter–Number Span Test, Trail Making Test A, and Personal and Social Performance Scale. They were administered atypical antipsychotics, starting with quetiapine. In the absence of a therapeutic response, another antipsychotic was introduced.Results: After 12 study months, the N-acetylaspartate/creatine (NAA/Cr) level did not significantly change at the whole-group level. Additional analysis revealed a significant rise in the NAA/Cr level in the study group that stayed on the same antipsychotic throughout the study course (P=0.008) and a significant drop in NAA/Cr in the study group that switched antipsychotics (P=0.005). On the whole-group level, no significant correlations between NAA/Cr values and other scores were found at either baseline or after 12 study months.Conclusion: One-year treatment with atypical antipsychotics administered to antipsychotic-naïve patients didn’t result in a significant rise in the NAA/Cr ratio. However, a significant rise was witnessed in the study group in which a satisfactory therapeutic response had been achieved with a single antipsychotic administration.Keywords: schizophrenia, atypical antipsychotics, NAA, MRS
format article
author Grošić V
Folnegović Grošić P
Kalember P
Bajs Janović M
Radoš M
Mihanović M
Henigsberg N
author_facet Grošić V
Folnegović Grošić P
Kalember P
Bajs Janović M
Radoš M
Mihanović M
Henigsberg N
author_sort Grošić V
title The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
title_short The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
title_full The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
title_fullStr The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
title_full_unstemmed The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
title_sort effect of atypical antipsychotics on brain n-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
publisher Dove Medical Press
publishDate 2014
url https://doaj.org/article/1e9212947ea445d7855b9a8c311f956b
work_keys_str_mv AT groscaronicv theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT folnegovicgroscaronicp theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT kalemberp theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT bajsjanovicm theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT radoscaronm theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT mihanovicm theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT henigsbergn theeffectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT groscaronicv effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT folnegovicgroscaronicp effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT kalemberp effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT bajsjanovicm effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT radoscaronm effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT mihanovicm effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
AT henigsbergn effectofatypicalantipsychoticsonbrainnacetylaspartatelevelsinantipsychoticnaiumlvefirstepisodepatientswithschizophreniaapreliminarystudy
_version_ 1718403602103402496